ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.26
0.33%
US Tech 100
19,846.00
0.00%
S&P 500
5,631.22
0.28%
US Dollar vs CAD
1.36886
0.07%
Bitcoin
62,885.34
-3.04%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Hepion Pharmaceuticals Inc (PK) (CTRVP)

  7. Hepion Pharmaceuticals Inc (PK) (CTRVP) News

CTRVP

Hepion Pharmaceuticals (PK) (CTRVP)

Hepion Pharmaceuticals Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:CTRVP
DateTimeSourceHeadlineSymbolCompany
07/15/20244:17PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/11/20248:46AMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
03/07/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
03/06/20243:30PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
02/21/20247:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
02/21/20247:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
02/20/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
02/07/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
12/07/20237:41AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
11/28/20235:55AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
11/20/20232:59PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
10/31/20233:15PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
10/03/20234:22PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
10/02/20233:52PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
09/20/202310:27AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
09/19/20238:01AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
08/14/20233:12PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/14/20234:12PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
05/12/20233:19PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
04/10/20233:52PMEdgar (US Regulatory)Annual Report (10-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
04/03/20235:02AMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
11/21/20224:08PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
11/14/20223:38PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
11/09/20224:21PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
11/09/20225:07AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
10/17/20224:14PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
08/05/20223:07PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/26/20223:06PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/25/20226:13AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/05/20227:34AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:CTRVP

Your Recent History

BIT
P1BG03
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved